Call Options Transactions Made in Q3 2024 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q3 2024. The information is specifically focused on institutions that hold call options of Ultragenyx Pharmaceutical Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 07, 2024
Q3 2024
|
Lmr Partners LLP
London, X0 |
BUY
|
CALL |
30KNew |
$1.21M - $1.78M
|
30K
$1.27M
|
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
30KNew |
$1.21M - $1.78M
|
30K
$1.27M
|
|
|
Nov 13, 2024
Q3 2024
|
Torno Capital, LLC
Cohasset, MA |
BUY
|
CALL |
30KNew |
$1.21M - $1.78M
|
30K
$1.27M
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
28.9K+ 17.46% |
$1.16M - $1.72M
|
194K
$8.22M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
26.6KNew |
$1.07M - $1.58M
|
26.6K
$1.12M
|
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
BUY
|
CALL |
16KNew |
$643K - $950K
|
16K
$676K
|
|
|
Nov 14, 2024
Q3 2024
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
CALL |
15.5KNew |
$623K - $920K
|
15.5K
$655K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
11.4K+ 48.72% |
$458K - $677K
|
34.8K
$1.47M
|
|
|
Nov 13, 2024
Q3 2024
|
Peak6 Investments LLC
Chicago, IL |
BUY
|
CALL |
8.5KNew |
$342K - $505K
|
8.5K
$359K
|
|
|
Nov 12, 2024
Q3 2024
|
Valence8 Us LP
Cambridge, MA |
BUY
|
CALL |
6.9KNew |
$277K - $410K
|
6.9K
$292K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
CALL |
-15K- 37.5% |
$603K - $890K
|
25K
$1.06M
|